Yong-Fen Qi (Yongfen Qi)

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 5

Top Topics

Endoplasmic Reticulum Stress

Top Venues

Oxidative medicine and cellular longevity

Journal of cardiovascular pharmacology and therapeutics

Cell death & disease

This page only lists publications with an associated author ORCID identifier.

Publications

Yao Chen, Yong-Fen Qi, Wei-Wei Lu
Endogenous Vasoactive Peptides and Vascular Aging-Related Diseases. Oxidative medicine and cellular longevity 2022 (2022)
Lin-Shuang Zhang, Jin-Sheng Zhang, Yue-Long Hou, Wei-Wei Lu, Xian-Qiang Ni, Fan Lin, Xiu-Ying Liu, Xiu-Jie Wang, Yan-Rong Yu, Mo-Zhi Jia, Chao-Shu Tang, Ling Han, San-Bao Chai, Yong-Fen Qi
Intermedin 1-53 Inhibits NLRP3 Inflammasome Activation by Targeting IRE1α in Cardiac Fibrosis. Inflammation 45 (4) (2022)
Yanjing He, Yun Sun, Chengcheng Liao, Fan Lin, Zheng-Yuan Xia, Yong-Fen Qi, Yahong Chen
The Protective Role of Hydrogen Sulfide and Its Impact on Gene Expression Profiling in Rat Model of COPD. Oxidative medicine and cellular longevity 2022 (2022)
Jin-Ling Ren, Yao Chen, Lin-Shuang Zhang, Ya-Rong Zhang, Shi-Meng Liu, Yan-Rong Yu, Mo-Zhi Jia, Chao-Shu Tang, Yong-Fen Qi, Wei-Wei Lu
Intermedin1-53 attenuates atherosclerotic plaque vulnerability by inhibiting CHOP-mediated apoptosis and inflammasome in macrophages. Cell death & disease 12 (5) (2021)
Jin-Ling Ren, Yue-Long Hou, Xian-Qiang Ni, Qing Zhu, Yao Chen, Lin-Shuang Zhang, Xin Liu, Chang-Ding Xue, Ning Wu, Yan-Rong Yu, Chao-Shu Tang, Zhong-Ping Ning, San-Bao Chai, Yong-Fen Qi
Intermedin1-53 Ameliorates Homocysteine-Promoted Atherosclerotic Calcification by Inhibiting Endoplasmic Reticulum Stress. Journal of cardiovascular pharmacology and therapeutics 25 (3) (2019)